Auna (NYSE:AUNA) Stock Rating Lowered by Wall Street Zen

Auna (NYSE:AUNA) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Sunday.

Other analysts also recently issued reports about the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research note on Wednesday, June 24th. JPMorgan Chase & Co. lowered their target price on shares of Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Finally, Zacks Research lowered Auna from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 31st. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $6.97.

Auna Price Performance

Shares of NYSE:AUNA opened at $5.28 on Friday. The company’s fifty day moving average price is $4.87 and its 200 day moving average price is $5.03. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.09 and a quick ratio of 1.00. Auna has a 12 month low of $4.09 and a 12 month high of $6.85. The firm has a market capitalization of $390.40 million, a P/E ratio of 20.29 and a beta of 0.62.

Auna (NYSE:AUNA) last posted its earnings results on Friday, May 15th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.14). Auna had a net margin of 1.53% and a return on equity of 16.25%. The firm had revenue of $336.84 million during the quarter, compared to analysts’ expectations of $320.54 million. As a group, sell-side analysts predict that Auna will post 0.81 earnings per share for the current fiscal year.

Insider Buying and Selling at Auna

In related news, President Leon Jesus Zamora acquired 30,000 shares of the company’s stock in a transaction dated Tuesday, May 26th. The stock was bought at an average price of $4.39 per share, with a total value of $131,700.00. Following the purchase, the president directly owned 45,914 shares in the company, valued at $201,562.46. The trade was a 188.51% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director John Wilton sold 17,574 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $4.17, for a total transaction of $73,283.58. Following the transaction, the director owned 49,974 shares in the company, valued at approximately $208,391.58. The trade was a 26.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders acquired a total of 83,454 shares of company stock valued at $357,063 over the last quarter.

Hedge Funds Weigh In On Auna

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Renaissance Technologies LLC raised its stake in Auna by 487.7% during the first quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock worth $3,683,000 after purchasing an additional 554,707 shares during the period. Marshall Wace LLP grew its stake in shares of Auna by 391.0% during the 4th quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock valued at $802,000 after buying an additional 129,799 shares during the period. Lazard Asset Management LLC purchased a new stake in shares of Auna during the 1st quarter valued at $557,000. Hsbc Holdings PLC acquired a new stake in shares of Auna during the 1st quarter worth $324,000. Finally, Arrowstreet Capital Limited Partnership purchased a new position in shares of Auna in the 1st quarter worth $316,000.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.